Despite the powerful anti-tumor function of immunotherapies based on the interaction between peptide-MHC molecules and TCRs, tumor cells can escape immune surveillance by down-regulating peptide-MHC complex expression (90). This evidence concerns the gene HLA-C and neoplasm.